Yantao L. Han

308 Ningxia Road
Qingdao, 266071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 66 publications

Discovery of New Butyrylcholinesterase Inhibitors and Evaluation of Their Biological Activity against Alzheimer's Disease.

Discovery of New Butyrylcholinesterase Inhibitors and Evaluation of Their Biological Activity against Alzheimer's Disease.

Journal: ACS chemical neuroscience

Published: June 23, 2026

MIAT: An important long non-coding RNA regulating cardiovascular and cerebrovascular diseases.

MIAT: An important long non-coding RNA regulating cardiovascular and cerebrovascular diseases.

Journal: Frontiers in cardiovascular medicine

Published: January 21, 2026

Albumin-based synergistic chemiexcited photodynamic biomimetic nanoreactor overcoming adaptive immune resistance for enhanced cancer immunotherapy.

Albumin-based synergistic chemiexcited photodynamic biomimetic nanoreactor overcoming adaptive immune resistance for enhanced cancer immunotherapy.

Journal: International journal of biological macromolecules

Published: March 05, 2025

Rasal2 inhibits autophagic-exosomes secretion via regulating Rab27a in triple-negative breast cancer progression.

Rasal2 inhibits autophagic-exosomes secretion via regulating Rab27a in triple-negative breast cancer progression.

Journal: Journal of translational medicine

Published: February 27, 2025

Aerosol inhalation of rhIL-10 improves acute lung injury in mice by affecting pulmonary neutrophil phenotypes through neutrophil-platelet aggregates.

Aerosol inhalation of rhIL-10 improves acute lung injury in mice by affecting pulmonary neutrophil phenotypes through neutrophil-platelet aggregates.

Journal: International immunopharmacology

Published: October 23, 2024

Synergistic Anti-Tumor Efficacy Achieved by Reversing Drug Resistance through the Regulation of the Tumor Immune Microenvironment with IL-12 and Osimertinib Combination Therapy.

Synergistic Anti-Tumor Efficacy Achieved by Reversing Drug Resistance through the Regulation of the Tumor Immune Microenvironment with IL-12 and Osimertinib Combination Therapy.

Journal: Journal of Cancer

Published: February 17, 2024

The repeated administration of rhIL-12 for 14 weeks in rhesus monkeys: A toxicity assessment.

The repeated administration of rhIL-12 for 14 weeks in rhesus monkeys: A toxicity assessment.

Journal: Journal of applied toxicology : JAT

Published: August 09, 2023

Codelivery of Que and BCL-2 siRNA with Lipid-Copolymer Hybrid Nanocomplexes for Efficient Tumor Regression.

Codelivery of Que and BCL-2 siRNA with Lipid-Copolymer Hybrid Nanocomplexes for Efficient Tumor Regression.

Journal: ACS biomaterials science & engineering

Published: July 18, 2023

A Novel Bromophenol Compound from Leathesia nana Inhibits Breast Cancer in a Direct Tumor Killing and Immunotherapy Manner.

A Novel Bromophenol Compound from Leathesia nana Inhibits Breast Cancer in a Direct Tumor Killing and Immunotherapy Manner.

Journal: Molecules (Basel, Switzerland)

Published: May 22, 2023

RIP1 Mediates Manzamine-A-Induced Secretory Autophagy in Breast Cancer.

RIP1 Mediates Manzamine-A-Induced Secretory Autophagy in Breast Cancer.

Journal: Marine drugs

Published: January 15, 2023

Electrospun Chitosan-Polyvinyl Alcohol Nanofiber Dressings Loaded with Bioactive Ursolic Acid Promoting Diabetic Wound Healing.

Electrospun Chitosan-Polyvinyl Alcohol Nanofiber Dressings Loaded with Bioactive Ursolic Acid Promoting Diabetic Wound Healing.

Journal: Nanomaterials (Basel, Switzerland)

Published: July 30, 2022

A Novel Polysaccharide From Chuanminshen violaceum and Its Protective Effect Against Myocardial Injury.

A Novel Polysaccharide From Chuanminshen violaceum and Its Protective Effect Against Myocardial Injury.

Journal: Frontiers in nutrition

Published: June 04, 2022

Showing 1-12 of 66

Last Updated: 09/26/2026